July 18, 2007 -- Implantable contraceptives are highly effective for preventing pregnancy and seem to be well tolerated by the women who use them, a review of the research shows. The combined analysis included nine studies comparing different implantable contraceptives. More than four out of five wo
May 22, 2007 -- The FDA has approved Lybrel, the first low-dose contraceptive pill that gives women an option to stop their menstrual cycle for an indefinite period of time. However, women using Lybrel will most likely have unplanned breakthrough bleeding or spotting, according to the FDA. Women sho
April 17, 2007 - So-called morning-after contraception works for individual women, but it isn’t working to lower unwanted pregnancy rates at the population level, an analysis of the research shows. Researchers concluded that easy access to emergency contraception (involving higher doses of hormones
Dec. 13, 2006 -- Menstrual periods may soon be just another lifestyle choice for American women. The continuous oral contraceptive Lybrel was shown to be highly effective for eliminating monthly bleeding in a yearlong study. The study was published in the December issue of the journal Contraception.
Dec. 8, 2006 - A spearmint-flavored, chewable birth-control pill is now available by prescription at U.S. drug stores. Introduced last September as Ovcon 35 Chewable, it is now dubbed Femcon Fe by Warner Chilcott, which markets the chewable made by Bristol Myers Squibb. The pill may be chewed -- fol
By Janis Graham The Pill isn't just for birth control: Did you know that it can also protect against certain life-threatening cancers, plus help relieve some painful period symptoms? Here, experts explain the top seven health benefits of taking the Pill and how to make them work for you.
Nov. 1, 2006 -- The hunt for a male contraceptive pill may have a new target: a protein called Gba2. Male mice lacking that protein are infertile, scientists report in The Journal of Clinical Investigation. Curbing Gba2 might serve as a male contraceptive, the researchers suggest. They included Davi
Oct. 31, 2006 -- Women who take oral contraceptives have a slightly increased risk of developing breast cancer early in life, with the risk being greatest for women who use oral birth control before they have their first child, a new analysis suggests. Researchers combined the findings from 34 previ
Oct. 30, 2006 -- Scientists report promising results with a male contraceptive drug tested on rats. The drug, called Adjudin, is a long way from human use. But lab tests on rats showed no signs of side effects, and the drug's effects wore off in 20 weeks. The researchers included Chuen-yan Cheng, Ph
Sept. 20, 2006 -- The Ortho Evra patch is getting new labeling with more information on the risk of nonfatal blood clots associated with the patch. The clotting risk isn't new, and the patch's warning about that risk isn't being strengthened. The label change simply adds information from two observa